K. Selinger et al., DETERMINATION OF REMIFENTANIL IN HUMAN AND DOG-BLOOD BY HPLC WITH UV DETECTION, Journal of pharmaceutical and biomedical analysis, 12(2), 1994, pp. 243-248
Remifentanil (GI87084) is a phenylaminopiperidine derivative of the fe
ntanyl type with a potent analgesic activity and ultra-short half-life
. The N-substituted labile methyl propanoate ester group is highly sus
ceptible to cleavage by endogenous esterases and by chemical hydrolysi
s. The hydrolysis is stopped by addition of 20 mul of 50% citric acid
per 1 ml of blood. The method involves a liquid extraction of chilled
blood at pH 7.4 with butyl chloride and back-extraction into 0.01 M HC
l. The chromatographic conditions are: column - Zorbax SB-CN 4.6 x 250
mm; mobile phase -7% acetonitrile-14% methanol in phosphate buffer (0
.03 M; pH 3.0); detection - UV at 210 nm. The internal standard used w
as GI97559 - an ethyl analogue of the drug. The method has been valida
ted in human blood over the range of 1-200 ng ml-1 and in dog over the
range 10-60, 135 ng ml-1 with the latter assay being used in a toxico
logical support study. Additionally, it was used to characterize the h
ydrolysis of the drug, the enzymes involved in the process, and ex viv
o drug interactions.